Technical Analysis for SDGR - Schrodinger, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Flat | Down | Down |
| Historical SDGR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.00% | |
| Crossed Above 20 DMA | Bullish | -3.93% | |
| Narrow Range Bar | Range Contraction | -3.93% | |
| NR7 | Range Contraction | -3.93% | |
| Inside Day | Range Contraction | -3.93% | |
| Fell Below 20 DMA | Bearish | -1.86% | |
| Narrow Range Bar | Range Contraction | -5.94% | |
| NR7 | Range Contraction | -5.94% | |
| Multiple of Ten Bearish | Other | -5.94% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Down 5% | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
| Fell Below 200 DMA | 1 day ago |
| 200 DMA Support | 1 day ago |
| Down 3% | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2020
Schrödinger, Inc. provides chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. Schrödinger was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in August 1990 and is headquartered in New York, NY.
Sector: Healthcare
Industry: Health Information Services
Keywords: Pharmaceutical Industry Software Solutions Drug Discovery Materials Science Simulation Software Pre Clinical Development
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Pharmaceutical Industry Software Solutions Drug Discovery Materials Science Simulation Software Pre Clinical Development
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 117.0 |
| 52 Week Low | 35.8 |
| Average Volume | 1,253,570 |
| 200-Day Moving Average | 74.02 |
| 50-Day Moving Average | 88.51 |
| 20-Day Moving Average | 75.91 |
| 10-Day Moving Average | 75.17 |
| Average True Range | 5.48 |
| ADX | 18.12 |
| +DI | 22.39 |
| -DI | 32.81 |
| Chandelier Exit (Long, 3 ATRs ) | 67.21 |
| Chandelier Exit (Short, 3 ATRs ) | 81.00 |
| Upper Bollinger Band | 84.31 |
| Lower Bollinger Band | 67.52 |
| Percent B (%b) | 0.38 |
| BandWidth | 22.11 |
| MACD Line | -3.03 |
| MACD Signal Line | -4.03 |
| MACD Histogram | 0.9919 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 80.25 | ||||
| Resistance 3 (R3) | 80.58 | 78.80 | 79.19 | ||
| Resistance 2 (R2) | 78.80 | 77.18 | 78.63 | 78.83 | |
| Resistance 1 (R1) | 76.35 | 76.19 | 75.46 | 76.02 | 78.48 |
| Pivot Point | 74.57 | 74.57 | 74.13 | 74.40 | 74.57 |
| Support 1 (S1) | 72.12 | 72.95 | 71.23 | 71.79 | 69.32 |
| Support 2 (S2) | 70.34 | 71.96 | 70.17 | 68.97 | |
| Support 3 (S3) | 67.89 | 70.34 | 68.61 | ||
| Support 4 (S4) | 67.56 |
